Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Delsys Pharmaceutical Corp.

Division of Perrigo Co. PLC

Latest From Delsys Pharmaceutical Corp.

Delsys Pharmaceutical Corp.

Delsys Pharmaceuticals hopes to simplify the process of drug formulation for pharmaceutical companies with an automated technology called {Accudep}. {Accudep} uses an electrostatic deposition technology to manufacture, using minimal excipients, all sorts of pharmaceuticals based on dry powder.
BioPharmaceutical Research and Development Strategies

Drug Delivery Start-ups

Knowing that the competition's tougher, the new crop of drug delivery companies grows increasingly specialized.
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Perrigo Co. PLC
  • Senior Management
  • David King, Pres. & CEO
    Ronald H Spair, VP, Fin. & CFO
    Nancy M Gray, PhD, VP, Corp. Dev.
    Troy Harmon, Dir., Bus. Dev.
  • Contact Info
  • Delsys Pharmaceutical Corp.
    Phone: (732) 329-3407
    11 Deer Park Dr. Ste. 202
    Monmouth Junction, NJ 08852